RxDoctor Payments Data

Kevin Ragothaman

Podiatrist · Cupertino, CANPI 1699138735

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (44.3%), education and food and beverage — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Arthrex at 46.1% of the total. Reporting peaked in 2020 at $12,385 and has fallen 84.3% since, to $1,939 in 2025. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,591in general payments, 2019–2025

Across 90 payments — averaging $251.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$10K
  • Evolution Surgical, Inc$5K
  • CDC Medical LLC$2K
  • Stryker$918
  • Biotissue Holdings Inc.$848
  • Paragon 28, Inc.$568
  • plus $3K from 21 others

What the payments were for

  • Grants$10,00044%
  • Travel & lodging$7543%
  • Food & beverage$5,08623%
  • Education$6,75130%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,591 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California

Other podiatrist in Cupertino

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →